Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapy

Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapy

US Patent 12269902 · Granted Apr 8, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Peptide compounds and peptide conjugates for the treatment of cancer through rec2023
Peptide compounds and peptide conjugates for the treatment of cancer through rec2023
Peptide compounds and peptide conjugates for the treatment of cancer through rec2023
Peptide compounds and peptide conjugates for the treatment of cancer through rec2023
Peptide compounds and peptide conjugates for the treatment of cancer through rec2023
Peptide compounds and peptide conjugates for the treatment of cancer through rec2023
Peptide compounds and peptide conjugates for the treatment of cancer through rec2021
Peptide compounds and peptide conjugates for the treatment of cancer through rec2021
Peptide compounds and peptide conjugates for the treatment of cancer through rec2021
Peptide compounds and peptide conjugates for the treatment of cancer through rec2021
Peptide compounds and peptide conjugates for the treatment of cancer through rec2021
Peptide compounds and peptide conjugates for the treatment of cancer through rec2021